Wilkins – Experimental Therapeutics

The development and use of new medicines remains a formidable challenge. In 2001, the pharmaceutical industry spent $44 billion on research and development of new agents. How well that money will not be apparent for another decade or more. It now costs an average of ł550 million ($800 million) to bring a drug to market, more than twice as much as in 1987. Much of this money (perhaps up to 70%) is spent on drugs that fail on the path to licensing. As a rule of thumb, for every 10,000 molecules s